INSM: Insmed Incorporated
INSM exchange rate has changed by -0.31% for today. During the day, the instrument was traded at a low of 125.62 and at a high of 128.24.
Follow Insmed Incorporated dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
INSM News
- Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
- Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?
- Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?
- Alger Mid Cap 40 ETF Q2 2026 Portfolio Review
- Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
- Biotech Is Booming, But These 2 Stocks Missed the Memo - Moderna (NASDAQ:MRNA), iShares Biotechnology ETF
- Artisan Global Opportunities Fund Q2 2026 Portfolio Review
- Top Analyst Reports for Visa, Lam Research & Caterpillar
- Alger Small Cap Growth Fund Q2 2026 Portfolio Review
- Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake
- Artisan Global Discovery Fund Q2 2026 Portfolio Activity
- Insmed Catapults 30%, Leading A Biotech Rally. But Mirum Takes A Bath.
- Insmed (INSM) Reports Q2 Earnings: What Key Metrics Have to Say
- Insmed Incorporated 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:INSM) 2026-08-06
- Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
- Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates
- Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
- Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
- Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
Frequently Asked Questions
What is INSM stock price today?
Insmed Incorporated stock is priced at 126.29 today. It trades within 125.62 - 128.24, yesterday's close was 126.68, and trading volume reached 3943. The live price chart of INSM shows these updates.
Does Insmed Incorporated stock pay dividends?
Insmed Incorporated is currently valued at 126.29. Dividend policy depends on the company, while investors also watch -22.07% and USD. View the chart live to track INSM movements.
How to buy INSM stock?
You can buy Insmed Incorporated shares at the current price of 126.29. Orders are usually placed near 126.29 or 126.59, while 3943 and 0.23% show market activity. Follow INSM updates on the live chart today.
How to invest into INSM stock?
Investing in Insmed Incorporated involves considering the yearly range 90.39 - 212.75 and current price 126.29. Many compare 3.56% and -23.23% before placing orders at 126.29 or 126.59. Explore the INSM price chart live with daily changes.
What are Insmed Incorporated stock highest prices?
The highest price of Insmed Incorporated in the past year was 212.75. Within 90.39 - 212.75, the stock fluctuated notably, and comparing with 126.68 helps spot resistance levels. Track Insmed Incorporated performance using the live chart.
What are Insmed Incorporated stock lowest prices?
The lowest price of Insmed Incorporated (INSM) over the year was 90.39. Comparing it with the current 126.29 and 90.39 - 212.75 shows potential long-term entry points. Watch INSM moves on the chart live for more details.
When did INSM stock split?
Insmed Incorporated has gone through stock splits historically. These changes are visible in , 126.68, and -22.07% after corporate actions.
- Previous Close
- 126.68
- Open
- 126.00
- Bid
- 126.29
- Ask
- 126.59
- Low
- 125.62
- High
- 128.24
- Volume
- 3.943 K
- Daily Change
- -0.31%
- Month Change
- 3.56%
- 6 Months Change
- -23.23%
- Year Change
- -22.07%